Core Viewpoint - Hong Kong University of Science and Technology (HKUST) has signed cooperation agreements with two pharmaceutical companies in Shandong to advance collaboration in the biomedicine sector, focusing on research, talent development, and commercialization of scientific achievements [1][3]. Group 1: Collaboration Details - The agreements involve deep collaboration in areas such as preclinical and clinical research, exploration of cutting-edge scientific fields, talent training and exchange, and commercialization of research outcomes [3]. - The partnership with Boan Biotech will focus on developing new anti-cancer drugs and therapies, while the collaboration with Luye Pharma will concentrate on new treatments for neuroscience and central nervous system diseases, as well as advanced drug delivery systems [3]. Group 2: Talent Development and Innovation - Both companies will support HKUST in cultivating talent in the pharmaceutical innovation field, providing students with research and practical industry bases, as well as platforms for applying relevant scientific research technologies [3]. - HKUST aims to enhance its commercialization capabilities by integrating artificial intelligence with biomedicine, exploring smart drug development and data-driven clinical research to accelerate the translation of innovative results into precise and efficient medical solutions globally [4].
港科大与两家山东医药公司签署协议 深化生物医药领域合作